Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 2
2015 2
2016 1
2017 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases.
Hassan AHE, Kim HJ, Gee MS, Park JH, Jeon HR, Lee CJ, Choi Y, Moon S, Lee D, Lee JK, Park KD, Lee YS. Hassan AHE, et al. Among authors: jeon hr. J Enzyme Inhib Med Chem. 2022 Dec;37(1):768-780. doi: 10.1080/14756366.2022.2036737. J Enzyme Inhib Med Chem. 2022. PMID: 35196956 Free PMC article.
Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of Leishmania donovani.
Hassan AHE, Phan TN, Yoon S, Lee CJ, Jeon HR, Kim SH, No JH, Lee YS. Hassan AHE, et al. Among authors: jeon hr. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1922-1930. doi: 10.1080/14756366.2021.1969385. J Enzyme Inhib Med Chem. 2021. PMID: 34425714 Free PMC article.
Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase.
Hassan AHE, Wang CY, Lee CJ, Jeon HR, Choi Y, Moon S, Lee CH, Kim YJ, Cho SB, Mahmoud K, El-Sayed SM, Lee SK, Lee YS. Hassan AHE, et al. Among authors: jeon hr. Pharmaceuticals (Basel). 2023 Nov 13;16(11):1597. doi: 10.3390/ph16111597. Pharmaceuticals (Basel). 2023. PMID: 38004462 Free PMC article.
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib.
Lee SE, Choi SY, Bang JH, Kim SH, Jang EJ, Byeun JY, Park JE, Jeon HR, Oh YJ, Kim HJ, Kim YK, Park JS, Jeong SH, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Mauro MJ, Kim DW. Lee SE, et al. Among authors: jeon hr. Am J Hematol. 2013 Jun;88(6):449-54. doi: 10.1002/ajh.23427. Epub 2013 Mar 28. Am J Hematol. 2013. PMID: 23440689 Free article.
Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Byeun JY, Park JE, Jeon HR, Oh YJ, Yahng SA, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Lee JW, Min WS, Park CW, Kim DW. Lee SE, et al. Among authors: jeon hr. Hematology. 2014 Mar;19(2):63-72. doi: 10.1179/1607845413Y.0000000100. Epub 2013 Nov 25. Hematology. 2014. PMID: 23684143